Skip to content
10-Q

Quarterly Report

Q Therapeutics, Inc.

0001193125-14-201193

← back to feed
Filed
May 15, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 15, 2014 29.42M sh
Capex Q1 2014 · Mar 31, 2014 $436.89K
Capex Q1 2014 · Mar 31, 2013 $19.85K
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$17.69M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$120.3K
Stockholders Equity Q1 2014 · Mar 31, 2014 −$1.14M
Stockholders Equity Q1 2014 · Dec 31, 2013 −$3.04M
Current Liabilities Q1 2014 · Mar 31, 2014 $1.47M
Current Liabilities Q1 2014 · Dec 31, 2013 $3.3M
Current Assets Q1 2014 · Mar 31, 2014 $295.09K
Current Assets Q1 2014 · Dec 31, 2013 $221.53K
Total Assets Q1 2014 · Mar 31, 2014 $333.9K
Total Assets Q1 2014 · Dec 31, 2013 $257.04K
Sga Expense Q1 2014 · Mar 31, 2014 $11.09M
Sga Expense Q1 2014 · Mar 31, 2013 $374.72K
Rd Expense Q1 2014 · Mar 31, 2014 $13.28M
Rd Expense Q1 2014 · Mar 31, 2013 $131.11K
Net Income Q1 2014 · Mar 31, 2014 −$25.05M
Net Income Q1 2014 · Mar 31, 2013 −$499.28K
Operating Income Q1 2014 · Mar 31, 2014 −$22.98M
Operating Income Q1 2014 · Mar 31, 2013 −$500.33K
Gross Profit Q1 2014 · Mar 31, 2014 $1.39M
Gross Profit Q1 2014 · Mar 31, 2013 $5.5K
Cost Of Revenue Q1 2014 · Mar 31, 2014 $4.8K
Revenue Q1 2014 · Mar 31, 2014 $1.4M
Revenue Q1 2014 · Mar 31, 2013 $5.5K
Cash And Equivalents Q1 2014 · Mar 31, 2013 $654.05K
Cash And Equivalents Q1 2014 · Dec 31, 2012 $794.21K